Lipid-Lowering Medications Flashcards
Cholesterol recommendations:
Total <200
LDL <100
HDL 35-100
What is the MOA of HMG CoA Reductase Inhibitors?
These drugs inhibit HMG CoA Reductase which is responsible for the rate limiting step in the body’s natural production of cholesterol in hepatocytes. By inhibiting the biosynthesis of cholesterol there is an upregulation in LDL receptor expression in hepatocytes which increases uptake of plasma LDL into the hepatocytes and out of the systemic circulation
What are the HMG CoA Reductase Inhibitors in order of most potent to lease:
Rosuvastatin Atorvastatin Simvastatin Pravastatin Lovastatin Fluvastatin
AE of HMG CoA inhibitors:
Myopathy, myositis, rhabdomyolysis
Elevated transaminases
Monitor CK, transaminases, muscle ache complaints
What do atorvastatin, simvastatin, and lovastatin have in common?
They are all metabolized by CYP 3A4
Ex- Rotanavir is a potent CYP 3A4 inhibitor which can lead to toxic levels of simvastatin and lovastatin causing an increased risk for rhabdomyolysis
Cholestyramine, Colesevelam, and Colestipol are all:
Bile acid sequesterants
What is the MOA of bile acid sequesterants?
Cationic polymer resins that bind (noncovalent) to negatively charted bile acids in the small intenstine. The complex cannot be reabsorbed in the distal ileum and is excreted in the stool.
A decrease in the reabsorption of bile acids by the ileum partially interrupts enterohepatic bile acid circulation.
Hepatocytes up-regulate 7a-hydroxylase, the rate limiting step in bile acid synthesis.
The increase is bile acid synthesis decreases hepatocyte cholesterol concentration, LDL receptors increase, LDL clearance from the circulation increases
When should doses of bile acid sequesterants be administered?
After meals (frequent dosing)
Most AE of bile acid sequesterants are related to:
GI upset: bloating, dyspesia
How can some drug interactions be avoided with bile acid sequesterants?
To avoid binding with other drugs, separate dosing (1-2hrs to avoid)
MOA of Cholesterol Absorption Inhibitors:
Reduction of cholesterol absorption by the small intestine
This could cause increase in hepatic synthesis; often used in combination with another agent (statin)
Cholesterol Absorption Inhibitors include:
Ezetimibe (manufactured) Plant sterols (veg, fruit, supplements)
What effect do Fibrates have on cholesterol/triglycerides?
Increase HDL
Decrease Triglyceride synthesis
Fibrates include gemibrozil, fenofibrate, clofibrate. What are their AE:
GI discomfort
Increased transaminases
Myopathy, arrhythmia (rare)
*use with caution with statins d/t similarities in AE.
Two drug interactions that fibrates have include:
Fibrates displace warfarin from albumin increases free warfarin and raising INR
Fibrates increase cyclosporine clearance